Related Experiment Video
Updated: Jul 12, 2025

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways
Layla Haymour1, Mickael Jean2, Cristian Smulski3
1UMR CNRS 7276, INSERM U1262, CRIBL, Université Limoges, Limoges, France.
Abstract:
Although the interaction of CD95L (also known as FasL) with its so-called death receptor CD95 (Fas) induces an apoptotic signal responsible for the elimination of infected and cancer cells and maintenance of tissue homeostasis, this receptor can also implement non apoptotic signaling pathways. This latter signaling is involved in metastatic dissemination in certain cancers and the severity of auto-immune disorders. The signaling complexity of this pair is increased by the fact that CD95 expression itself seems to contribute to oncogenesis via a CD95L-independent manner and, that both ligand and receptor might interact with other partners modulating their pathophysiological functions. Finally, CD95L itself can trigger cell signaling in immune cells rendering complex the interpretation of mouse models in which CD95 or CD95L are knocked out. Herein, we discuss these non-canonical responses and their biological functions.
Insights
The CD95L/Fas pathway, known for apoptosis, also triggers non-apoptotic signals. These complex pathways impact cancer metastasis and autoimmune diseases, requiring further research for therapeutic insights.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- The CD95L (FasL) and CD95 (Fas) receptor-ligand pair primarily induces apoptosis for immune regulation and tumor suppression.
- Aberrant CD95L/Fas signaling is implicated in autoimmune diseases and cancer progression.
- Non-canonical signaling pathways of CD95L/Fas add complexity to their known functions.
Purpose of the Study:
- To explore the non-canonical, non-apoptotic signaling pathways of the CD95L/Fas system.
- To elucidate the biological functions of these alternative signaling routes.
- To discuss the implications for disease pathogenesis and research models.
Main Methods:
- Review and synthesis of existing literature on CD95L/Fas signaling.
- Analysis of studies investigating non-apoptotic functions.
- Discussion of findings in the context of cancer and autoimmune disorders.
Main Results:
- CD95L/Fas engagement mediates non-apoptotic signaling pathways.
- These pathways are involved in cancer metastasis and autoimmune disease severity.
- CD95 expression can promote oncogenesis independently of CD95L.
- Ligand and receptor interactions with other partners modulate functions.
- CD95L signaling in immune cells complicates mouse model interpretations.
Conclusions:
- The CD95L/Fas system exhibits complex non-canonical signaling with significant pathophysiological roles.
- Understanding these non-apoptotic functions is crucial for developing targeted therapies for cancer and autoimmune diseases.
- Further investigation is needed to fully decipher the intricacies of CD95L/Fas interactions and their therapeutic potential.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Non-Canonical Wnt Signaling Pathways
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Intracellular Signaling Affects Focal Adhesions
Some...

